Loading…
Loading…
EQUITY / NASDAQ · XNCM
DataMeds AI Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗3.68 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 3.68 USD · Volume 1,166,809
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 1,779,860 USD | 7,790,865 USD | -77.15% |
| Operating profit | -7,345,054 USD | -5,500,376 USD | — |
| Net income | -18,363,225 USD | -6,672,464 USD | — |
| Cash and cash equivalents | 2,456,373 USD | — | — |
| Total liabilities | 52,263,663 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 2,456,373 USD | — | — | 42,571 USD | 42,571 USD | 4,228,666 USD | — | — |
| Gross profitIncome statement | 182,204 USD | 352,425 USD | — | — | -6,426,419 USD | 231,012 USD | 1,429,405 USD | 505,752 USD |
| Net incomeIncome statement | -18,363,225 USD | -26,105,822 USD | -7,742,597 USD | — | -101,274,530 USD | -34,318,204 USD | -73,421,571 USD | -6,672,464 USD |
| Operating profitIncome statement | -7,345,054 USD | -13,360,592 USD | — | — | -93,749,097 USD | -31,548,329 USD | -68,397,073 USD | -5,500,376 USD |
| RevenueIncome statement | 1,779,860 USD | 3,339,423 USD | — | — | 23,337,860 USD | 3,012,904 USD | 21,667,212 USD | 7,790,865 USD |
| Total assetsBalance sheet | 32,759,432 USD | — | — | 30,459,449 USD | 30,459,449 USD | 52,779,540 USD | — | — |
| Total equityBalance sheet | -19,504,231 USD | — | -15,062,449 USD | -12,447,801 USD | -12,447,801 USD | 6,778,015 USD | — | 905,255 USD |
| Total liabilitiesBalance sheet | 52,263,663 USD | — | — | 42,907,250 USD | 42,907,250 USD | 46,001,525 USD | — | — |
| Financing cash flowCash flow statement | — | 9,168,360 USD | — | — | 10,750,790 USD | — | 8,388,250 USD | — |
| Investing cash flowCash flow statement | — | -447,230 USD | — | — | -881,526 USD | — | -626,144 USD | — |
| Operating cash flowCash flow statement | — | -6,307,328 USD | — | — | -10,855,029 USD | — | -4,561,776 USD | — |
| Report source | Open report ↗ Published: 08/17/2026 | Open report ↗ Published: 08/17/2026 | Open report ↗ Published: 08/17/2026 | Open report ↗ Published: 08/17/2026 | Open report ↗ Published: 03/20/2026 | Open report ↗ Published: 11/19/2025 | Open report ↗ Published: 11/19/2025 | Open report ↗ Published: 08/17/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.